ResearchToPractice.com/VPB110 – A 54yo woman with bipolar disorder is diagnosed with a 1.6-cm, Grade III, strongly ER+, weakly PR+, HER2-, node- IDC and an Oncotype DX RS of 32. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB110 – A 54yo woman develops painful, biopsyconfirmed triple-negative sternal mets 7 years after completion of adjuvant dose-dense AC paclitaxel. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB110 – A case-based discussion on the management of breast cancer featuring an interview with Joseph A Sparano, MD and Alan B Astrow, MD conducted by Neil Love, MD. CME Information and Program PDF. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 1: A 41-year-old woman with a metastatic ER-positive, HER2-negative invasive ductal carcinoma (IDC) after being treated two years ago with neoadjuvant AC followed by T, mastectomy, radiation therapy and tamoxifen. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 2: A 59-year-old woman with bone metastases two years after the diagnosis of a Grade II, node-positive, ER-positive, PR-positive, HER2-positive IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 3: A 72-year-old woman with cancer recurrence nine years after diagnosis of a 1-cm, poorly differentiated, node-positive, ER-positive, PR-negative, HER2-negative IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 4: A 51-year-old postmenopausal woman diagnosed five years ago with 4-cm and 1-cm node-positive, ER-positive, HER2-negative IDCs. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 5: A woman diagnosed nine years ago at the age of 42 with a 9-cm, ER-positive, PR-positive, HER2-positive IDC who has received multiple lines of therapy for metastatic disease. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 6: A 51-year-old postmenopausal woman with a 1.3-cm, Grade II, node-negative, ER-positive, PR-positive, HER2-negative IDC and an Oncotype DX® Recurrence Score® of 21 (intermediate risk). Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 7: A 50-year-old woman with rising tumor markers and a PET scan-documented solitary lesion in her rib four years after being diagnosed with a T1cN2aM0, ER-positive (10 percent), HER2-negative IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.